No Data
No Data
Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook
U.S. Apheresis Equipment (Disposable Kits, Device, Renal Disease, Neurology) Market Size, Share & Trends Analysis Report 2024-2030 - ResearchAndMarkets.com
Haemonetics' (NYSE:HAE) 14% CAGR Outpaced the Company's Earnings Growth Over the Same Three-year Period
Haemonetics (HAE) Banks on Growing Hospital Arm, New Launches
Thermo Fisher (TMO) Inks New Partnership for MyeloMATCH Trial
Does Haemonetics (NYSE:HAE) Have A Healthy Balance Sheet?